This shows you the differences between two versions of the page.
start [2016/10/16 15:59] f.demichelis@unitn.it |
start [2017/06/06 15:46] (current) f.demichelis@unitn.it |
||
---|---|---|---|
Line 4: | Line 4: | ||
The laboratory integrates computational and experimental work and is characterized by inter-disciplinary/inter-institutional collaborations that allow for a challenging and stimulating atmosphere and state-of-the-art approaches. | The laboratory integrates computational and experimental work and is characterized by inter-disciplinary/inter-institutional collaborations that allow for a challenging and stimulating atmosphere and state-of-the-art approaches. | ||
+ | |||
+ | Follow us on {{:twitter.png?30|[[https://twitter.com/FrancescaBZNY]]}} | ||
<html> | <html> | ||
Line 11: | Line 13: | ||
</html> | </html> | ||
+ | |||
+ | **June 5th 2017**: **ASCO 2017** Whole exome sequencing of circulating tumor DNA (ctDNA) in patients with neuroendocrine prostate cancer presented at ASCO 2017 was featured in UroToday. Collaboration with Weill Cornell Medicine.([[https://www.urotoday.com/conference-highlights/asco-2017/asco-2017-prostate-cancer/96283-asco-2017-whole-exome-sequencing-of-circulating-tumor-dna-ctdna-in-patients-with-neuroendocrine-prostate-cancer-informs-tumor-heterogeneity.html|article]]). | ||
+ | |||
+ | ---- | ||
+ | {{ :nature_genetics.jpg?nolink&130}} | ||
+ | **October 17th 2016**: [[http://www.nature.com/ng/journal/vaop/ncurrent/full/ng.3692.html|Clonal Evolution of Chemotherapy-resistant Urothelial Carcinoma]] Chemotherapy drives treatment resistance in bladder cancer as revealed by allele-specific CLONET based analysis of bladder cancer tissues. An international team-science collaborative work with Weill Cornell Medicine and the Englander Institute for Precision Medicine ([[http://weill.cornell.edu/news/news/2016/10/chemotherapy-drives-treatment-resistance-in-bladder-cancer.html|press release]]). | ||
+ | |||
+ | ---- | ||
**October 10th 2016**: [[http://www.cell.com/cancer-cell/fulltext/S1535-6108(16)30440-8|N-Myc Induces an EZH2-Mediated Transcriptional Program Driving Neuroendocrine Prostate Cancer]] A study from David Rickman's group with our collaboration published in Cancer Cell. | **October 10th 2016**: [[http://www.cell.com/cancer-cell/fulltext/S1535-6108(16)30440-8|N-Myc Induces an EZH2-Mediated Transcriptional Program Driving Neuroendocrine Prostate Cancer]] A study from David Rickman's group with our collaboration published in Cancer Cell. |